维普中文期刊产品整合服务
161篇 您的检索式:作者名="NIO N"
    题名 作者 年代 出处 被引量
1Relative peripheral refraction across 4 meridians after orthokeratology and LASIK surgery显示文摘Background:To characterize the axial and off-axis refraction across four meridians of the retina in myopic eyes before and after Orthokeratology(OK)and LASIK surgery.Methods:Sixty right eyes with a spherical equivalent(M)between−0.75 to−5.25 D(cylinder<−1.00 D)underwent LASIK(n=26)or OK(n=34)to treat myopia.Axial and off-axis refraction were measured with an open-field autorefractometer before and after stabilized treatments.Off-axis measurements were obtained for the horizontal(35°nasal and temporal retina)and vertical(15°superior and inferior retina)meridians,and for two oblique directions(45–225°and 135–315°)up to 20°of eccentricity.The refractive profile was addressed as relative peripheral refractive error(RPRE).Results:OK and LASIK post-treatment results showed an increase of myopic relative refraction at several eccentric locations.At the four meridians evaluated,the M component of the pre-treatment RPRE values was not statistically different(p>0.05)from the post-treatment RPRE within 30°and 20°of the central visual field after LASIK and OK,respectively.These results demonstrated that the treatment zone warrants an optimal central field of vision.Conclusions:The present study gives an overview of RPRE after refractive corneal reshaping treatments(OK and LASIK)across vertical,horizontal and two oblique meridians together.This allows a 3D representation of RPRE at the retina and shows that the myopic shift induced by both treatments is more relevant in horizontal directions.António Queirós Ana Amorim-de-Sousa Daniela Lopes-Ferreira César Villa-Collar Ángel Ramón Gutiérrez JoséManuel González-Méijome 2018Eye and Vision2018,5,1:8
2Biometric and ICL-related risk factors associated to sub-optimal vaults in eyes implanted with implantable collamer lenses显示文摘Background:To identify biometric and implantable collamer lens(ICL)-related risk factors associated with suboptimal postoperative vault in eyes implanted with phakic ICL.Methods:This study reports a retrospective case series of the first operated eye in 360 patients implanted with myopic spherical or toric ICL.Preoperatively,white-to-white(WTW),central keratometry(Kc)and central corneal thickness(CCT)were measured using the Pentacam.Anterior-segment optical coherence tomography(AS-OCT,Visante)was applied preoperatively for measuring the horizontal anterior-chamber angle-to-angle distance(ATA),internal anterior chamber depth(ACD),crystalline lens rise(CLR),anterior-chamber angle(ACA)and postoperatively the vault.Eyes were divided into three vault groups:low(LVG:≤250μm),optimal(OVG:>250 and<1000μm)and high(HVG:≥1000μm).Multinomial logistic regression(MLR)was used to find the sub-optimal vault predictors.Results:MLR showed that CLR,ICL size minus the ATA(ICL size-ATA),age,ICL spherical equivalent(ICLSE)and ICL size as contributing factors for sub-optimal vaults(pseudo-R2=0.40).Increased CLR(OR:1.01,CI:1.00-1.01)and less myopic ICLSE(OR:1.22,CI:1.07-1.40)were risk factors for low vaults.Larger ICL size-ATA(OR:41.29,CI:10.57-161.22)and the 13.7mm ICL(OR:7.08,CI:3.16-15.89)were risk factors for high vaults,whereas less myopic ICLSE(OR:0.85,CI:0.76-0.95)and older age(OR:0.92,CI:0.88-0.98)were protective factors.Conclusion:High CLR and low ICLSE were the major risk factors in eyes presenting low vaults.In the opposite direction,ICL size-ATA was the major contributor for high vaults.This relationship was more critical in higher myopic ICLSE,younger eyes and when 13.7mm ICL were used.The findings show that factors influencing the vault have differentiated weight of influence depending on the type of vault(low,optimal or high).Santiago Cerpa Manito Angel Sánchez Trancón Oscar Torrado Sierra António Manuel Baptista Pedro Miguel Serra 2021Eye and Vision2021,8,1:5
3Inhibition of angiotensin-converting enzyme by synthetic peptides of human β-casein 显示文摘Kohmura M Nio N Kubo K 1989Agricultural and Biological Chemistry1989,53,8:1
4Modulation of T lymphocyte function by neuropeptides 显示文摘Nio D A Moylan R N Roche J K 1993J lmmunol1993,150,:1
5Properties and applications of microbial transglutaminase显示文摘Yokoyama K N Nio Y Kikuchi 2004Applied Microbiology and Bioteehnology2004,64,4:1
6Properties and applications of microbial transglutaminase 显示文摘Yokoyama N Nio Kikuchi Y 2004Applied Microbiology and Biotechnology2004,64,:1
7Inhibition of angiotensin-converting enzyme by synthetic peptides of human β-casein显示文摘Kohmura M Nio N Kubo K 1989Agric Biol Chem1989,53,:1
8Some characteristics of a microbial protein cross-linking enzyme: transglutaminase 显示文摘Seguro K Nio N Motoki M 1996ACS Syrup Ser1996,650,:1
9Properties and applications of microbial transglutaminase显示文摘Yokoyama K Nio N & Kikuchi Y 2004Applied Microbial Biotechnology2004,64,:1
10Reduced invasiveness and metasta- sis of Chinese hamster ovary ceils transfected with human interleukin- 17 gene 显示文摘Hirahara N Nio Y Sasaki S 2000Anticancer Res2000,20,5:1
11Gelation mechanism of protein solution by transglutaminase显示文摘Nio N Motoki M & Takinami K 1986Agricultural and Biological Chemistry1986,50,:1
12Inhibition of angio tensin-converting enzyme by synthetic peptides of human β -casein显示文摘Kohmura M Nio N Kubo K 1989Agric Biol Chem1989,53,8:1
13Reduced invasiveness and metastasis of Chinese hamster ovary cells transfected with human interleukin-17 gene 显示文摘Hirahara N Nio Y Sasaki S 2000Anticancer Res2000,,:1
14Inhibition of angito-tensin con- vetting enzyme by synthetic peptides of human B-casein显示文摘KOHMURA M NIO N KUBO K 1989Agric Biol Chem1989,53,8:1
15Gelation of casein and soy- bean globulins by transglutaminase显示文摘NIO N MOTOKI M TAKINAMI K 1985Agric Bilo Chem1985,49,8:1
16Gelation of casein and soybean globulins by transglutaminase 显示文摘Nio N Motoki M Takinami K 1985Agric Biol Chem1985,48,:1
17Inhibition of angiotensin-converting enzyme by synthetic peptides of human β-casein显示文摘Kohmura M Nio N Kubo K 1989Agric Biol Chem1989,53,:1
18Gelation mechanism of protein solution by transglutaminase显示文摘Nio N Motoki M Takinami K 1986Agric Biol Chem1986,50,:1
19Inhibition of angiotensin I - converting enzyme by synthetic peptides of human K-casein显示文摘KOI-IMURA M NIO N ARIYOSHI Y 1990A- gricultural and Biological Chemistry1990,54,3:1
20Properties and applications of microbial transglutaminase显示文摘Yokoyama K Nio N Kikuehi Y 2004Applied Microbiology and Biotechnology2004,64,4:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费